carmot glp-1 Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacy GLP-1 boom causing pharma FOMO

Mingo is a GLP-1 tracker app for Ozempic, Mounjaro and Wegovy

By defining stages from no residue to severe obstruction, it enhances study comparisons and procedure planning while promoting a shared understanding among providers

Understanding your body's peptide response and genetic predispositions reveals why dosing, timing, and compound selection matter more than the medication name alone

AMP-activated protein kinase (AMPK) is an evolutionarily conserved serine/threonine kinase whose activation elicits insulin-sensitizing effects, making it an ideal therapeutic target for T2D

GLP-1 medications drive costs

Weightless: A Doctor's Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve